Loading...
Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System
Background: A variety of prescriptions and over-the-counter medications interfere with transcutaneous continuous glucose monitoring (CGM) sensors. This study characterized the interference profile of the Eversense(®) CGM System (Senseonics, Inc., Germantown, MD), which has a different mechanism of g...
Na minha lista:
| Udgivet i: | Diabetes Technol Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5963543/ https://ncbi.nlm.nih.gov/pubmed/29600877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0028 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|